EPISODE · Sep 12, 2026 · 5 MIN
What’s News in Markets: Amgen’s Prognosis, Quantum Boost, iPhone Makeover
from WSJ What’s News · host The Wall Street Journal
Why did a failed Novartis drug trial tank Amgen’s shares? And how is taxpayer money funding quantum-computing companies? Plus, will people pay $2,000 for a foldable iPhone? Host Imani Moise discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Embed this episode
Ready to play
What’s News in Markets: Amgen’s Prognosis, Quantum Boost, iPhone Makeover
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.